Slater Sentinel logo

The Latest Headlines at Slater Sentinel

Image about Citigroup Increases Micron Technology (NASDAQ:MU) Price Target to $150.00

Citigroup Increases Micron Technology (NASDAQ:MU) Price Target to $150.00

Micron Technology (NASDAQ:MU – Free Report) had its price target raised by Citigroup from $95.00 to $150.00 in a report issued on Friday, MarketBeat.com reports. They currently have a buy rating on the semiconductor manufacturer’s... More of this article »
Image about Perma-Fix Environmental Services (NASDAQ:PESI) Raised to Buy at StockNews.com

Perma-Fix Environmental Services (NASDAQ:PESI) Raised to Buy at StockNews.com

StockNews.com upgraded shares of Perma-Fix Environmental Services (NASDAQ:PESI – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. Separately, TheStreet upgraded Perma-Fix Environmental... More of this article »
Image about Contrasting eBay (NASDAQ:EBAY) & Americanas (OTCMKTS:BTOOY)

Contrasting eBay (NASDAQ:EBAY) & Americanas (OTCMKTS:BTOOY)

Americanas (OTCMKTS:BTOOY – Get Free Report) and eBay (NASDAQ:EBAY – Get Free Report) are both retail/wholesale companies, but which is the better stock? We will contrast the two businesses based on the strength of their... More of this article »
Image about Head-To-Head Contrast: Navios Maritime Partners (NYSE:NMM) and Toro (NASDAQ:TORO)

Head-To-Head Contrast: Navios Maritime Partners (NYSE:NMM) and Toro (NASDAQ:TORO)

Toro (NASDAQ:TORO – Get Free Report) and Navios Maritime Partners (NYSE:NMM – Get Free Report) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based... More of this article »
Image about BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of “Moderate Buy” by Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of “Moderate Buy” by Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are presently covering the company, MarketBeat Ratings reports. Two research... More of this article »
Image about CyberArk Software (NASDAQ:CYBR) Given New $315.00 Price Target at Bank of America

CyberArk Software (NASDAQ:CYBR) Given New $315.00 Price Target at Bank of America

CyberArk Software (NASDAQ:CYBR – Free Report) had its price target boosted by Bank of America from $300.00 to $315.00 in a report released on Friday, Benzinga reports. The brokerage currently has a buy rating on the technology... More of this article »
Image about TRX Gold (NYSE:TRX) Coverage Initiated at StockNews.com

TRX Gold (NYSE:TRX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of TRX Gold (NYSE:TRX – Free Report) in a research report report published on Saturday morning. The firm issued a hold rating on the stock. TRX Gold Stock Performance NYSE:TRX opened at... More of this article »
Image about Financial Analysis: PCS Edventures! (OTCMKTS:PCSV) vs. China Education Resources (OTCMKTS:CHNUF)

Financial Analysis: PCS Edventures! (OTCMKTS:PCSV) vs. China Education Resources (OTCMKTS:CHNUF)

PCS Edventures! (OTCMKTS:PCSV – Get Free Report) and China Education Resources (OTCMKTS:CHNUF – Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the two... More of this article »
Image about Escalade (NASDAQ:ESCA) vs. Fitell (NASDAQ:FTEL) Critical Survey

Escalade (NASDAQ:ESCA) vs. Fitell (NASDAQ:FTEL) Critical Survey

Escalade (NASDAQ:ESCA – Get Free Report) and Fitell (NASDAQ:FTEL – Get Free Report) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on... More of this article »
Image about Head-To-Head Analysis: Stryve Foods (NASDAQ:SNAX) versus Oxus Acquisition (NASDAQ:OXUS)

Head-To-Head Analysis: Stryve Foods (NASDAQ:SNAX) versus Oxus Acquisition (NASDAQ:OXUS)

Oxus Acquisition (NASDAQ:OXUS – Get Free Report) and Stryve Foods (NASDAQ:SNAX – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on... More of this article »
Image about Brokerages Set Healthpeak Properties, Inc. (NYSE:PEAK) Target Price at $23.05

Brokerages Set Healthpeak Properties, Inc. (NYSE:PEAK) Target Price at $23.05

Healthpeak Properties, Inc. (NYSE:PEAK – Get Free Report) has been assigned an average recommendation of “Hold” from the ten analysts that are covering the firm, MarketBeat reports. One research analyst has rated... More of this article »
Image about Autodesk, Inc. (NASDAQ:ADSK) Receives $270.78 Average Price Target from Analysts

Autodesk, Inc. (NASDAQ:ADSK) Receives $270.78 Average Price Target from Analysts

Autodesk, Inc. (NASDAQ:ADSK – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nineteen brokerages that are presently covering the company, Marketbeat.com reports. One equities research... More of this article »
Image about Amgen Inc. (NASDAQ:AMGN) Receives $295.30 Average PT from Brokerages

Amgen Inc. (NASDAQ:AMGN) Receives $295.30 Average PT from Brokerages

Amgen Inc. (NASDAQ:AMGN – Get Free Report) has received an average recommendation of “Hold” from the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research... More of this article »
Image about Clearwater Analytics Holdings, Inc. (NYSE:CWAN) Receives $21.77 Consensus Target Price from Analysts

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) Receives $21.77 Consensus Target Price from Analysts

Shares of Clearwater Analytics Holdings, Inc. (NYSE:CWAN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com... More of this article »
Image about Baker Hughes (NASDAQ:BKR) Receives $40.44 Average PT from Analysts

Baker Hughes (NASDAQ:BKR) Receives $40.44 Average PT from Analysts

Baker Hughes (NASDAQ:BKR – Get Free Report) has been given an average rating of “Moderate Buy” by the fifteen analysts that are covering the firm, Marketbeat reports. Three research analysts have rated the stock... More of this article »